Cambridge Consultants creates blockchain-based platform to help manage drug costs

Cambridge Consultants has developed a public blockchain trading platform for drug price negotiation. The platform uses smart contracts on the Ethereum blockchain to enable and authorise trades, including contracts for FDA approvals. The aim is to create a transparent system that benefits all stakeholders, from pharmaceutical companies to patients, by fostering price competition and improving access to drugs.